Preliminary report: trials on the use of BCG vaccine as adjuvant immunotherapeutic agent in treatment of acute lymphoblastic leukemia in Egypt.
D000276:Adjuvants, Immunologic; D001500:BCG Vaccine / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D007167:Immunotherapy; D007945:Leukemia, Lymphoid / Q000628:therapy*; D008297:Male
D000276:Adjuvants, Immunologic; D001500:BCG Vaccine